α-Adrenoceptors and vascular regulation: Molecular, pharmacologic and clinical correlates

Pharmacology and Therapeutics

Volumn 72, Issue 3, 1996, Pages 215-241

  Piascik, Michael T ^a   Soltis, Edward E ^a   Piascik, Mary M ^a   Macmillan, Leigh B ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 and 2 AR subtypes, AR subtype cloning; ligand 1 AR interactions, vascular smooth muscle regulation by ARs; therapeutic use of AR agonists and antagonists

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; MEPHENTERMINE; METARAMINOL; METHOXYAMINE; PHENOXYBENZAMINE; PHENTOLAMINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HYPERPLASIA; HYPERTENSION; IMPOTENCE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAYNAUD PHENOMENON; RECEPTOR GENE; REVIEW; SMOOTH MUSCLE;

CLONING, MOLECULAR; GTP-BINDING PROTEINS; HUMANS; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0030446899     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00117-9     Document Type: Review

References (273)

1. 1-adrenoceptor. Pharmacol. Commun. 6: 29-38.
2. Ahlquist, R. P. (1948) A study of the adrenotropic receptors. Am. J. Physiol. 153: 586-600.
3. 2-adrenoceptor-mediated inhibitory regulation of human platelet adenylate cyclase. Naunyn Schmiedebergs Arch. Pharmacol 324: 196-200.
4. 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268: 22235-22238.
5. Ariens, E. J. (1954) Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory. Arch. Int. Pharmadocyn. 99: 32-49.
6. Babich, M., Pedigo, N. W., Butler, B. T. and Piascik, M. T. (1987) Heterogeneity of alpha-1-receptors associated with vascular smooth muscle: evidence from functional and ligand binding studies. Life Sci. 41: 663-673.
7. Berridge, M. J. (1993) Inositol triphosphate and calcium signalling. Nature 361: 315-325.
8. Berthelsen, S. and Pettinger, W. A. (1977) A functional basis for the classification of alpha adrenergic receptors. Life Sci. 21: 595-606.
9. Be van, J. A. (1981) A comparison of the contractile responses of the rabbit basilar and pulmonary arteries to sympathomimetic agonists: further evidence for variation in vascular adrenoceptor characteristics. J. Pharmacol. Exp. Ther. 216: 83-89.
10. Blaxall, H. S., Murphy, T. J., Baker, J. C., Ray, C. and Bylund, D. B. (1991) Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther. 259: 323-329.
11. 2-adrenergic receptor genes in rat tissues. Receptor 4: 191-199.
12. 1A-adrenoceptors in rat kidney. Br. J. Pharmacol. 107: 414-417.
13. Bodelsson, G. and Stjernquist, M. (1995) Characterization of contractile adrenoceptors in the human umbilical artery. Eur. J. Pharmacol. 282: 95-101.
14. Boer, R., Grassegger, A., Schudt, C. H. and Glossman, H. (1989) (+)-Niguldipine binds with very high affinity to Ca++ channels and to a subtype of alphal-adrenoceptors. Eur. J. Pharmacol. 172: 131-145.
15. Bond, W. S. (1986) Psychiatric indications for clonidine: the neuropharmacologic and clinical basis. J. Clin. Psychopharmacol. 6: 81-87.
16. Bravo, E. V., Tarazi, R. C., Fouad, R. M., Vidt, D. G. and Gifford, R. W. (1981) The clonidine suppression test: a useful aid in the diagnosis of pheochromocytoma. N. Engl. J. Med. 305: 623-626.
17. Brown, G. L. and Gillespie, J. S. (1957) The output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.) 138: 81-102.
18. Buccafusco, J. J. (1990) Participation of different brain regions in the antinarcotic withdrawal action of clonidine in the dependent rat. Brain Res. 513: 8-14.
19. Bucher, B., Ouedraogo, S., Tschopl, M., Paya, D. and Stoclet, J-C. (1992) Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br. J. Pharmacol. 107: 976-982.
20. Bullock, G. R., Taylor, S. G. and Weston, A. H. (1986) Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br. J. Pharmacol. 89: 819-830.
21. Bylund, D. B. (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav. 22: 835-843.
22. Bylund, D. B., Ray-Prenger, C. and Murphy, T. J. (1988) Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther. 245: 600-607.
23. Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., Jr. and Trendelenburg, U. (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46: 121-136.
24. Bylund, D. B., Regan, J. W., Faber, J. E., Hieble, J. P., Triggle, C. R. and Ruffolo, R. R., Jr. (1995) Vascular α-adrenoceptors: from the gene to the human. Can. J. Physiol. Pharmacol. 73: 533-543.
25. Carrier, G. O. and White, R. E. (1985) Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasocontraction by removal of endothelium in rat aorta. J. Pharmacol. Exp. Ther. 232: 682-687.
26. Carstairs, K. C., Breckenridge, A., Dollery, C. T. and Worlledge, S. M. (1966) Incidence of a positive direct Coombs' test in patients on methyldopa. Lancet ii: 133-135.
27. 2-adrenergic receptor-G-protein interactions. J. Biol. Chem. 269: 29557-29564.
28. 2A-adrenergic receptor to multiple G-proteins. J. Biol. Chem. 269: 5730-5734.
29. 2-adrenergic receptor complementary cDNA from rat brain. Mol. Cell. Biochem. 97: 161-172.
30. 1-adrenoceptor sybtypes in vitro and in situ. J. Biol. Chem. 270: 30980-30988.
31. Cheung, D. W. (1985) An electrophysiological study of α-adrenoceptor mediated excitation-contraction coupling in the smooth muscle cells of the rat saphenous vein. Br. J. Pharmacol. 84: 265-271.
32. 2-C2 adrenergic receptor. Biochem. Biophys. Res. Commun. 186: 1280-1287.
33. Clark, A. J. (1937) General Pharmacology, Handbuch der Vol. 4. Springer-Verlag, Berlin.
34. Clark, J. T., Smith, E. R. and Davidson, J. M. (1984) Enhancement of sexual motivation in male rats by yohimbine. Science 225: 847-849.
35. 19-adrenoceptors in mouse but not in the rabbit anococcygeus preparation. Br. J. Pharmacol. 78: 117-122.
36. Coates, J., Jahn, U. and Weetman, D. F. (1982) The existence of a new subtype of alpha-adrenoceptor is revealed by SGD 100/75 and phenoxybenzamtne. Br. J. Pharmacol. 75: 549-552.
37. Coffman, J. D. (1991) Raynaud's phenomenon: an update. Hypertension 17: 593-602.
38. Cole, P., Haight, J. S. J., Cooper, P. W. and Kassel, E. E. (1983) A computed tomographic study of nasal mucosa: effects of vasoactive substances. J. Otolaryngol. 12: 58-60.
39. 1 adrenergic receptor occupation and norepinephrine-stimulated calcium flux in cultured vascular smooth muscle cells. Mol. Pharmacol. 27: 517-524.
40. Cooke, J. P., Rimele, T. J., Flavahan, N. A. and Vanhoutte, P. M. (1985) Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein. J. Pharmacol. Exp. Ther. 234: 598-602.
41. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 85: 7159-7163.
42. Cotecchia, S., Kobilka, B. K., Daniel, K. W., Nolan, R. D., Lapetina, E. G., Caron, M. G., Lefkowitz, R. J. and Regan, J. W. (1990) Multiple second messenger pathways of α-adrenergic receptor subtypes expressed in eukaryotic cells. J. Biol. Chem. 265: 63-69.
43. Cubeddu, L. X. (1988) New alphaj-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am. Heart J. 116: 133-162.
44. Cumming, A. M., Brown, J. J., Lever, A. F. and Robertson, J. I. (1982) Intravenous labetalol in the treatment of severe hypertension. Br. J. Clin. Pharmacol. 13 (Suppl): 93s-96s.
45. Dale, H. H. (1906) On some physiological actions of ergot. J. Physiol. 34: 163-206.
46. Davies, J. (1985) Selective inhibition of responses of feline horn neurons to noxious cutaneous stimuli by tizanidine and noredrenaline: involvement of alpha-2 adrenoceptors. Neuroscience 16: 673-682.
47. De Bernardis, J. F., Winn, M., Kerkman, D. J., Kyuel, J. J., Buckner, S. and Horrom, B. (1987) A new nasal decongestant, A-57219: a comparison with oxymetazoline. J. Pharm. Pharmacol. 39: 760-763.
48. 2 subtypes in rat vasculature in vitro and in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 326: 1-6.
49. de Jonge, A. (1988) Vascular α-adrenoceptors and the regulation of vascular tone. ISI Atlas of Science. Pharmacol. 2: 303-307.
50. 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ. Res. 67: 1535-1551.
51. DeMeyts, P. and Rousseau, G. G. (1980) Receptor concepts. A century of evolution. Circ. Res. 46 (Suppl. I): 13-19.
52. Dixon, R. A. F., Sigal, I. S., Candelore, M. R., Register, R. B. and Scattergood, W. (1987) Structural features required for ligand binding to the β-adrenergic receptor. EMBO J. 6: 3269-3275.
53. Docherty, J. R. and Starke, K. (1982) An examination of the preand postsynaptic α-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein. Br. J. Pharmacol. 76: 327-335.
54. 2-adrenergic receptor. Biochemistry 29: 2335-2342.
55. Dollery, C. T. and Reid, J. L. (1973) Central noradrenergic neurons and the cardiovascular actions of clonidine in the rabbit. Br. J. Pharmacol. 47: 206-216.
56. Drew, G. M. and Whiting, S. B. (1979) Evidence for two distinct types of postsynaptic α-adrenoceptors in vascular smooth muscle in vivo. Br. J Pharmacol. 67: 207-215.
57. Dubocovich, M. L. and Langer, S. Z. (1974) Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre-and post-synaptic adrenergic receptors. J. Physiol. (Lond.) 237: 505-519.
58. Dyck, J. B., Maze, M., Haack, C., Vuorilehto, L. and Shafer, S. F. (1993) The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 78: 813-820.
59. Dyke, A. C. and Widdop, R. E. (1987) Characterization of postjunctional α-adrenoceptors in the rat isolated perfused femoral artery. Eur. J. Pharmacol. 137: 15-23.
60. Egan, T. M., Henderson, G., North, R. A. and Williams, J. T. (1983) Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurons. J. Physiol. 345: 477-488.
61. Egleme, C., Godfraind, T. and Miller, R. C. (1984) Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br. J. Pharmacol. 81: 16-18.
62. Ehrlich, P. (1913) Chemotherapeutics: scientific principles, methods and results. Lancet 185: 445-451.
63. 1-adrenoceptor alkylation in the rat and its effect on the vascular pressor response. J. Pharmacol. Exp. Ther. 260: 709-713.
64. Eyssette, M., Rohmer, F., Serratrice, G., Warter, J. M. and Boisson, D. (1988) Multicentre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis. Curr. Med. Res. Opin. 10: 699-708.
65. Faber, J. E. (1988) In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ. Res. 62: 37-50.
66. 1-adrenoceptor classification. Eur. J. Pharmacol. 268: 141-149.
67. Ferris, C. D. and Snyder, S. H. (1992) Inositol 1,4,5 trisphosphate-activated calcium channels. Ann. Rev. Physiol. 54: 469-488.
68. 1-adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci. 7: 347-349.
69. Flavahan, N. A., Rimele, T. J., Cooke, J. P. and Vanhoutte, P. M. (1984) Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J. Pharmacol. Exp. Ther. 230: 699-705.
70. 1B-adrenergic receptor subcellular distribution and function. J. Biol. Chem. 270: 8902-8909.
71. 1C subtype. Mol. Pharmacol. 45: 703-708.
72. Frick, M. H. (1987) Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension. Am. J. Cardiol. 59: 61G-67G.
73. Frisk-Holmberg, M., Paalzow, L. and Wibell, L. (1984) Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man. Eur. J. Clin. Pharmacol. 26: 309-313.
74. Furchgott, R. F. (1972) The classification of adrenoceptors (adrenergic receptors): an evaluation from the standpoint of receptor theory. In: Catecholamines, pp. 283-335, Blaschko, H. and Muscholl, E. (eds.) Springer-Verlag, Berlin.
75. Furchgott, R. F. and Bursztyn, P. (1967) Comparison of dissociation constants and relative efficacies of selected agonists acting on parasympathetic receptors. Ann. NY Acad. Sci. 144: 882-899.
76. Gaddum, J. H. (1926) The action of adrenalin and ergotamine on the uterus of the rabbit. J. Physiol. (Lond.) 61: 141-150.
77. 1B-adrenergic receptor. Gene 131: 243-247.
78. 1B-adrenergic receptor gene in liver is controlled by three promoters. J. Biol. Chem. 269: 15762-15767.
79. 2-Adrenoceptors in rat resistance vessels. Naunyn Schmiedebergs Arch. Pharmacol. 322: 29-33.
80. Glassman, A. H., Stetner, F., Walsh, T. B., Raizman, P. S., Fleiss, J. L., Cooper, T. B. and Covey, L. S. (1988) Heavy smokers, smoking cessation and clonidine. JAMA 259: 2863-2866.
81. 2C-adrenoceptor. Br. J. Pharmacol. 107: 222-225.
82. 1-adrenoceptors. Eur. J. Pharmacol. 272: R5-R6.
83. Gold, M. S., Redmond, D. E. and Kleber, H. D. (1978) Clonidine blocks acute opiate withdrawal symptoms. Lancet ii: 599-602.
84. 1-Adrenergic receptor subtypes: molecular structure, function and signalling. Circ. Res., in press.
85. Grigg, M. J., Nicolaides, A. N., Papadakis, K. and Wolfe, J. H. (1989) The efficacy of thymoxamine in primary Raynaud's phenomenon. Eur. J. Vasc. Surg. 3: 309-313.
86. Grimm, R. H., Jr. (1991) Antihypertensive therapy: taking lipids into consideration. Am. Heart J. 122 (Part 2): 910-918.
87. Gross, G., Hanft, G. and Rugevics, C. (1988) 5-Methylurapidil discriminates between subtypes of the alphal-adrenoceptor. Eur. J. Pharmacol. 151: 333-335.
88. 1-adrenergic receptors. Cell. Signal, in press.
89. 2-adrenergic receptor. J. Biol. Chem. 265: 17307-17317.
90. Hamed, A. T., Johnson, T. D., Charlton, K. G. and Clarke, D. E. (1983) Pharmacological characterization of α-adrenoreceptor subtypes in rat isolated thoracic aorta. J. Auton. Pharmacol. 3: 265-273.
91. Hamed, A. T., Jandhyala, B. S. and Lokhandwala, M. F. (1986) Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature. J. Pharmacol. Exp. Ther. 238: 599-605.
92. Hamilton, C. A. (1992) The role of imidazoline receptors in blood pressure regulation. Pharmacol. Ther. 54: 231-248.
93. 2+ in smooth muscle. Nature 329: 333-335.
94. 1-adrenoceptors revealed by chlorethylclonidine. Mol. Pharmacol. 32: 505-510.
95. 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol, 190: 97-104.
96. Hanft, G. and Gross, G. (1989) Subclassification of alphal-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol, 97: 671-700.
97. Hieble, J. P. and Ruffolo, R. R. (1991) Therapeutic applications of agents interacting with α-adrenoceptors. Prog. Basic Clin. Pharmacol. 8: 180-220.
98. Hieble, J. P. and Ruffolo, R. R. (1994) Alpha 1-adrenoceptors: pharmacological subclassification and therapeutic applications. Proc. West Pharmacol. Soc. 37: 163-167.
99. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47: 267-270.
100. Holck, M. I., Jones, C. H. H. and Haeusler, G. (1983) Differential interaction of clonidine and methoxamine with post-synaptic alpha-adrenoceptors of rabbit main pulmonary artery. J. Cardiovasc. Pharmacol. 5: 240-248.
101. Holmes, B. and Sorkin, E. M. (1986) Indoramin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway dieases. Drugs 31: 467-491.
102. Holz, G. G., IV, Rane, S. G. and Dunlap, K. (1986) GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 319: 670-672.
103. 1-adrenoceptor subtypes. Br. J. Pharmacol. 116: 1611-1618.
104. Horn, J. P. and McAffee, D. A. (1980) Alpha-adrenergic inhibition of calcium-dependent potentials in rat sympathetic neurones. J. Physiol. 301: 191-204.
105. 1MF-2 cells. J. Biol. Chem. 268: 3610-3615.
106. 1-adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol. 268: H1006-H1014.
107. 2 receptors on a cloned muscle cell line, BC3A-1. Mol. Pharmacol. 22: 258-266.
108. Hunt, R. D. (1987) Treatment effects of oral and transdermal clonidine in relation to methylphenidate - an open pilot study in ADDH. Psychopharmacol. Bull. 23: 111-114.
109. 1-adrenergic receptor agonist binding and activation. J. Biol. Chem. 271: 6322-6327.
110. 1-adrenergic receptor subtype selective binding. J. Biol. Chem. 270: 23189-23195.
111. 1B-adrenergic receptor mRNA in vascular smooth muscle cells. J. Biol. Chem. 269: 1705-1710.
112. Jampel, J. D., Robin, A. L., Wuigley, H. A. and Pollack, I. P. (1988) Apraclonidine: a one week dose-response study. Arch. Opthalmol. 106: 1069-1073.
113. Johnson, R. D. and Minneman, K. P. (1987) Differentiation of alpha1-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Mol. Pharmacol. 31: 239-246.
114. Jonler, M., Riehmann, M. and Bruskewitz, R. C. (1994) Benign prostatic hyperplasia. Current pharmacological treatment. Drugs 47: 66-81.
115. Kanasaki, M., Matsubara, H., Murasawa, S., Masaki, H., Nio, Y. and Inada, M. (1994) cAMP responsive element mediated regulation of the gene transcription of the alpha 1B adrenergic receptor by thyrotropin. J. Clin. Invest. 94: 2245-2254.
116. Kaneko, K. and Sunano, S. (1993) Involvement of α-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Eur. J. Pharmacol. 240: 195-200.
117. 1 blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group. J. Urol. 144: 908-911.
118. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J. Biol. Chem. 268: 8003-8011.
119. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115: 981-986.
120. 1B-adrenergic receptor by all amino acid substitution at a single site. J. Biol. Chem. 267: 1430-1433.
121. Knepper, S. M., Buckner, S. A., Brune, M. E., DeBarnardis, J. F., Meyer, M. D. and Hancock, A. A. (1995) A-61603, a potent α1-adrenergic receptor agonist, selective for the α1A receptor subtype. J. Pharmacol. Exp. Ther. 274: 97-103.
122. 2-adrenergic receptor. Science 238: 650-656.
123. 1-adrenoceptors of the rat. J. Pharmacol. Exp. Ther. 249: 70-77.
124. Langer, S. Z. (1974) Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23: 1793-1800.
125. Langer, S. Z. (1981) Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32: 337-362.
126. Langer, S. Z. and Hicks, P. E. (1984) Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol. 6: S547-S558.
127. Langer, S. Z. and Schoemaker, H. (1989) Alpha-adrenoceptor subtypes in blood vessels: physiology and pharmacology. Clin. Exp. Hypertens. A11 (Suppl. 1): 21-30.
128. 2-adrenoceptor. Trends Pharmcol. Sci. 3: 440-444.
129. Langley, J. N. (1905) On the reaction of cells of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and curari. J. Physiol. (Lond.) 33: 374-413.
130. 2-adrenergic receptors. J. Biol. Chem. 263: 14491-14496.
131. 2-adrenergic receptor. J. Biol. Chem. 266: 10470-10478.
132. 1A subtype. Mol. Pharmacol. 48: 414-422.
133. Leech, C. J. and Faber, J. E. (1996) Different α-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. - Heart Circ. Physiol. 39: H710-H722.
134. 1-adrenoceptor antagonist in the lower urinary tract. Br. J. Pharmacol. 109: 1282-1289.
135. 2A-adrenoceptor subtypes stimulate voltage-operated L-type calcium channels in rat portal vein myocytes. J. Biol. Chem. 269: 29546-29552.
136. Limbird, L. E. (1988) Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 2: 2686-2695.
137. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol. Pharmacol. 42: 16-27.
138. 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc. Natl. Acad. Sci. USA 87: 5094-5098.
139. 1A-adrenergic receptor. J. Biol. Chem. 266: 6365-6369.
140. Lorenz, W., Lomasney, J. W., Collins, S., Regan, J. W., Caron, M. G. and Lefkowitz, R. J. (1990) Expression of three α2-adrenergic receptor subtypes in rat tissues: implications for α2-receptor classification. Mol. Pharmacol. 38: 599-603.
141. Luther, R. R., Glassman, H. N., Estep, C. B., Maureth, C. J. and Jordan, D. C. (1989) The effects of terazosin and methyclothiazide on blood pressure and serum lipids. Am. Heart J. 117: 842-847.
142. Luttrell, L. M., Ostrowski, J., Cotecchia, S., Kendall, H. and Lefkowitz, R. J. (1993) Antagonism of catecholamine expression of cytoplasmic domains of the receptors. Science 259: 1453-1457.
143. Macia, R. A., Matthews, W. D., Lafferty, J. and DeMarinis, R. M. (1984) Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments. Naunyn Schmiedebergs Arch. Pharmacol. 325: 306-309.
144. 2-agonists. Science, in press.
145. 2-C10 adrenergic receptors expressed in Rat 1 fibroblasts can regulate both adenylylcyclase and phospholipase D-mediated hydrolysis of phosphatidylcholine by interacting with pertussis toxin-sensitive guanine nucleotide-binding proteins. J. Biol. Chem. 267: 2149-2156.
146. 1-Adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J. Biol. Chem. 265: 1082-1088.
147. 1c-adrenoceptor: functional characterization in prostate. Br. J. Pharmacol. 107: 327P.
148. Martinotti, E. (1991) α-Adrenergic receptor subtypes on vascular smooth musculature. Pharmacol. Res. 24: 297-306.
149. 2 adrenergic receptors involves multiple subsites. EMBO J. 9: 1471-1476.
150. Matthews, W. D., Jim, K. F., Hieble, J. P. and DeMarinis, R. M. (1984) Postsynaptic a adrenoceptors on vascular smooth muscle. Fedn. Proc. 43: 2923-2928.
151. McGrath, J. C. (1982) Evidence for more than one type of postjunctional α-adrenoceptor. Biochem. Pharmacol. 31: 467-484.
152. 2-Adrenoceptors mediate sympathetic vasoconstriction in distal segments of rat tail artery. Eur. J. Pharmacol. 108: 281-287.
153. Medgett, I. C. and Langer, S. Z. (1984) Heterogeneity of smooth muscle alpha adrenoceptors in the rat tail artery in vitro. J. Pharmacol. Exp. Ther. 229: 823-830.
154. Medgett, I. C. and Rajanayagam, M. A. S. (1984) Effects of reduced calcium ion concentration and of diltiazem on vasoconstrictor responses to noradrenaline and sympathetic nerve stimulation in rat isolated tail artery. Br. J. Pharmacol. 83: 889-898.
155. Medgett, I. C. and Ruffolo, R. R., Jr. (1988) Alpha adrenoceptor-mediated vasoconstriction in rat hindlimb: innervated alpha-2 adrenoceptors in the saphenous arterial bed. J. Pharmacol. Exp. Ther. 246: 249-254.
156. Michaelis, L. and Menten, M. L. (1913) Die kenestik der invertinwirkung. Biochem. Z. 49: 333-369.
157. 2B-adrenoceptor subtypes. Br. J. Pharmacol. 98: 890-897.
158. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 91: 10109-10113.
159. 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur. J. Pharmacol. 118: 123-129.
160. 1-Adrenergic receptor subtypes, inositol phosphates and sources of cell calcium. Pharmacol. Rev. 40: 87-119.
161. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 34: 117-133.
162. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol. Pharmacol. 33: 509-514.
163. 2+ channels by alpha 1A-and alpha 2A-adrenoceptors in vascular myocytes: involvement of different transduct ion pathways. Cell. Signal. 7: 471-479.
164. Mizobe, T., Maze, M., Lam, V., Suryanarayana, S. and Kobilka, B. K. (1996) Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin. J. Biol. Chem. 271: 2387-2389.
165. Morita, K. and North, R. A. (1981) Clonidine activates membrane potassium conductance in myenteric neurones. Br. J. Pharmacol. 74: 419-428.
166. 1-adrenergic receptor mRNA. J. Biol. Chem. 266: 2233-2238.
167. 3H] prazosin binding. Mol. Pharmacol. 29: 321-330.
168. Mulry, J. T. (1985) Guanabenz therapy for opiate withdrawal. Drug Intell. Clin. Pharm. 19: 32-33.
169. Murakami, K., Karaki, H. and Urakawa, N. (1985) Role of endothelium in the contractions induced by norepinephrine and clonidine in rat aorta. Jpn. J. Pharmacol. 39: 357-364.
170. 1-adrenoceptors. Pharmacol. Commun. 6: 23-28.
171. Murphy, T. J. and Bylund, D. B. (1988) Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J. Pharmacol. Exp. Ther. 244: 571-578.
172. 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria. Naunyn Schmiedebergs Arch. Pharmacol. 336: 280-286.
173. Nagamani, M., Kelver, M. E. and Smith, E. R. (1987) Treatment of menopausal hot flashes with transdermal administration of clonidine. Am. J. Obstet. Gynecol. 156: 561-565.
174. 2-adrenoceptor? Clin. Sci. 68 (Suppl. 10): 39s-42s.
175. 2+ in vascular smooth muscle. J. Hypertens. 12 (Suppl. 10): S133-S143.
176. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol. Pharmacol. 37: 30-36.
177. Nakaoka, H., Perez, D. M., Back, K. J., Das, T., Hogain, A., Misono, K., Im, M-J. and Graham, R. M. (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signalling function. Science 264: 1593-1596.
178. 1A adrenergic receptor-stimulated prostaglandin synthesis. J. Pharmacol. Exp. Ther. 263: 987-996.
179. Neusy, A. J. and Lowenstein, J. (1986) Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension. Am. J. Med. 80: 94-99.
180. 2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 57: 143-151.
181. 2-adrenoceptors in the cardiovascular system of the pithed rat. Eur. J. Pharmacol. 145: 345-349.
182. Nickerson, M. (1956) Receptor occupancy and tissue response. Nature 178: 697-698.
183. 2-adrenoceptors. Br. J. Pharmacol. 99: 31-34.
184. Nielsen, H., Pilegaard, H. K., Hasenkam, J. M., Mortensen, F. V. and Mulvany, M. J. (1991) Heterogeneity of postjunctional α-adrenoceptors in isolated mesenteric resistance arteries from rats, rabbits, pigs, and humans. J. Cardiovasc. Pharmacol. 18: 4-10.
185. 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ. Res. 68: 232-244.
186. 2-adrenoceptors and endothelium-derived relaxing factor. Circ. Res. 71: 188-200.
187. Okazaki, M., Hu, Z. W., Fujinaga, M. and Hoffman, B. B. (1994) Alpha-1-adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J. Clin. Invest. 1: 208-210.
188. 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB 4101 and nifedipine. J. Vasc. Res. 29: 33-40.
189. 2-adrenoceptors. Br. J. Pharmacol. 106: 568-573.
190. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40: 876-883.
191. 1D-adrenergic receptors to multiple signalling pathways is both G protein and cell type specific. Mol. Pharmacol. 44: 784-795.
192. 1A-subtype. Mol. Pharmacol. 46: 823-831.
193. Perez, D. M., Hwa, J., Gaivin, R., Mathur, M., Brown, F. and Graham, R. M. (1996) Constitutive activation of a single effect pathway: evidence for multiple activation states of a G-protein. Mol. Pharmacol. 49: 112-122.
194. 3H]yohimbine binding in human brain. Life Sci. 38: 2129-2137.
195. 1 receptors with a chemically reactive analog of prazosin reveals low affinity sites for norepinephrine in rabbit aorta. J. Pharmacol. Exp. Ther. 246: 1001-1011.
196. 1-adrenoceptor subtypes. J. Pharmacol. Exp. Ther. 254: 982-991.
197. Piascik, M. T., Sparks, M. S. and Pruitt, T. A. (1991) Interaction of imidazolines with alkylation-sensitive and resistant alpha-1 adrenoceptor subtypes. J. Pharmacol. Exp. Ther. 258: 158-165.
198. Piascik, M. T., Smith, M. S., Barron, K. W. and Solus, E. E. (1993) The regulation of regional hemodynamics by alphal-adrenoceptor subtypes in the conscious rat. J. Pharmacol. Exp. Ther. 267: 1250-1255.
199. 1-adrenoceptors in vascular smooth muscle. Mol. Pharmacol. 46: 30-40.
200. Piascik, M. T., Guarino, R. D., Smith, M. S., Soltis, E. E., Saussy, D. L. and Perez, D. M. (1995) The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275: 1583-1589.
201. 1-adrenergic receptors in the regulation of peripheral vascular function. Pharmacol. Commun., in press.
202. Ping, P. and Faber, J. E. (1993) Characterization of α-adrenoceptor gene expression in arterial and venous smooth muscle. Am. J. Physiol. 265: H1501-H1509.
203. 1-adrenergic receptor subtypes in human tissues: implications for human α-adrenergic physiology. Mol. Pharmacol. 45: 171-175.
204. Quan, D. B., Wandres, D. L. and Schroeder, D. J. (1993) Clonidine in pain management. Ann. Pharmacother. 27: 313-315.
205. 1B-adrenergic receptor. J. Biol. Chem. 267: 21936-21945.
206. 2-adrenoceptors in the vasculature of the rat tail. Br. J. Pharmacol. 114: 1724-1730.
207. 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. USA 85: 6301-6305.
208. Reid, D., Morales, A., Harris, C., Surridge, D. H. C., Condra, M., Owen, J. and Fenemore, J. (1987) Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet ii: 421-423.
209. Reis, J. D., Golanov, E. V., Ruggiero, D. A. and Sun, M. K. (1994) Sympatho-excitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the systemic and cerebral circulations. J. Hypertens. 12: S159-S180.
210. Remaury, A. and Paris, H. (1992) The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. J. Pharmacol. Exp. Ther. 260: 417-426.
211. Robertson, D., Goldberg, M. R., Hollister, A. S., Wade, D. and Robertson, R. M. (1983) Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am. J. Med. 74: 193-200.
212. Ruffolo, R. R., Jr. (1982) Important concepts of receptor theory. J. Auton. Pharmacol. 2: 277-295.
213. Ruffolo, R. R., Jr., Turowski, B. S. and Patil, P. N. (1977) Lack of cross desensitization between structurally dissimiliar alpha-adrenoceptor agonists. J. Pharm. Pharmacol. 29: 378-380.
214. Ruffolo, R. R., Jr., Nichols, A. J., Stadel, J. M. and Hieble, J. P. (1991) Structure and function of α-adrenceptors. Pharmacol. Rev. 43: 475-505.
215. 2-adrenoceptor subtypes. Annu. Rev. Pharmacol. Toxicol. 32: 243-279.
216. 1B-adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J. Clin. Invest. 88: 385-389.
217. Sattler, R. W. and van Zwieten, P. A. (1967) Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur. J. Pharmacol. 2: 9-13.
218. Schwinn, D. A., Lomasney, J. N., Loreng, W., Szklut, P. J., Fremeau, R. T., Yang-Feng, T. L., Caron, M. G., Lefkowitz, R. J. and Cotecchia, S. (1990) Molecular cloning and expression of cDNA for a novel α-adrenergic receptor subtype. J. Biol. Chem. 265: 8183-8189.
219. 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol. Pharmacol. 40: 619-626.
220. Shipton, E. A. (1991) Alpha-adrenergic agonists in anesthesia and analgesia. S. Afr. Med. J. 79: 578-579.
221. Sidi, A. A. (1988) Vasoactive intracavernous pharmacotherapy. Urol. Clin. North Am. 15: 95-101.
222. 2D-adrenergic receptors in bovine pineal gland. Mol. Pharmacol. 40: 235-241.
223. 1-adrenergic response. J. Clin. Invest. 72: 732-738.
224. Skarby, T. and Andersson, K.-E. (1984) Contraction-mediating α-adrenoreceptors in isolated human omental, temporal, and pial arteries. J. Auton. Pharmacol. 4: 219-229.
225. 2-adrenoceptor mediating contractions of the human saphenous vein. Br. J. Pharmacol. 106: 447-451.
226. Smith, M. S., Soltis, E. E. and Piascik, M. T. (1992) Chloroethylclonidine sensitive alpha1-adrenoceptor subtypes and the regulation of renal blood flow in the conscious rat. Pharmacol. Commun. 2: 195-202.
227. Starke, K. (1972) α-Sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch. Pharmacol. 274: 18-45.
228. Starke, K. (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77: 1-124.
229. Starke, K., Endo, T. and Taube, H. D. (1975) Relative pre-and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch. Pharmacol. 291: 55-78.
230. Starksen, N. F., Simpson, P. C., Bishopric, N., Coughlin, S. R., Lee, W. M., Escobedo, J. A. and Williams, L. T. (1986) Cardiac myocytic hypertrophy is associated with c-myc protooncogene expression. Proc. Natl. Acad. Sci. USA 87: 2456-2460.
231. Stephenson, R. P. (1956) A modification of receptor theory. Br. J. Pharmacol. 11: 379-393.
232. Stokes, G. S. and Marwood, J. F. (1984) Review of the use of α-adrenoceptor antagonists in hypertension. Methods Fund. Exp. Clin. Pharmacol. 6: 197-204.
233. Strader, C. D., Sigal, I. S., Register, R. B., Candelore, M. R., Rands, E. and Dixon, R. A. F. (1987) Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84: 4384-4388.
234. Strader, C. D., Sigal, I. S., Candelore, M. R., Rands, E., Hill, W. S. and Dixon, R. A. F. (1988) Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263: 10267-10271.
235. Strader, C. D., Candelore, M. R., Hill, W. S., Sigal, I. S. and Dixon, R. A. F. (1989) Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J. Biol. Chem. 264: 13572-13578.
236. Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D. and Dixon, R. A. F. (1994) Structure and function of G-protein-coupled receptors. Ann. Rev. Biochem, 63: 101-132.
237. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 257: 977-980.
238. + exchange block stimulus-provoked arachidonic acid release in human platelets. J. Biol. Chem. 260: 12910-12919.
239. 2 activation in human platelets. J. Biol. Chem. 261: 8667-8673.
240. Tanaka, C. and Nishizuka, Y. (1994) The protein kinase C family for neuronal signalling. Annu. Rev. Neurosci. 17: 551-567.
241. 2D-adrenergic receptor contraction of arteriolar smooth muscle and reversal of contraction by hypoxia. Circ. Res. 76: 53-63.
242. 1-adrenoceptor constriction by acidosis and hypoxia in vitro. Am. J. Physiol. 268: H2068-H2076.
243. 2B-adrenergic receptor subtypes in brain. Hypertension 27: 449-455.
244. Tesfamariam, B., Weisbrod, R. M. and Cohen, R. A. (1987) Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation. Am. J. Physiol. 253: H792-H798.
245. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 57: PL159-PL163.
246. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1993) The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch. Intern. Med. 153: 154-183.
247. Tian, W-N., Gupta, S. and Deth, R. C. (1990) Species differences in chlorethylclonidine antagonism at vascular alpha-1 adrenergic receptors. J. Pharmacol. Exp. Ther. 253: 877-883.
248. 2-type by BHT 933. Eur. J. Pharmacol. 63: 199-202.
249. 1-adrenoceptor mediated vasoconstriction in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 324: 239-245.
250. 1-adrenoceptor agonists by the inhibition of its presser responses by calcium entry blockade and vasodilation in pithed rats and cats. Eur. J. Pharmacol. 96: 187-192.
251. 1-Adrenoceptor antagonism and haemodynamic effects of UK-52,046 cinoard with prazosin. Br. J. Pharmacol. 27: 686P-687P.
252. Tornebrandt, K., Nobin, A. and Owman, C. (1985) Pharmacological characterization of alpha-adrenergic receptor subtypes mediating contraction in human mesenteric arteries and veins. Blood Vessels 22: 179-195.
253. 125I]-BE2254. Life Sci. 34: 639-646.
254. 2 agonist binding sites in rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agonists. Brain Res. 319: 69-101.
255. Urabe, M., Kawasaki, H. and Takasaki, K. (1991) Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br. J. Pharmacol. 102: 85-90.
256. 2-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 316: 288-293.
257. Van Zwieten, P. A. (1988) Antihypertensive drugs interacting with α-and β-adrenoceptors: a review of basic pharmacology. Drugs 35 (Suppl. 6): 6-19.
258. Vargas, H. M. and Gorman, A. J. (1995) Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci. 57: 2291-2308.
259. 1-adrenoceptors in the pressor response to sympathetic nerve stimulation in the pithed rat. J. Pharmacol. Exp. Ther. 271: 748-754.
260. 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth. Analg. 67: 611-615.
261. 2-C4 adrenergic receptor gene encodes a novel pharmacological subtype. FEBS Lett. 278: 45-50.
262. Waldo, R. (1979) Prazosin relieves Raynaud's vasospasm. JAMA 241: 1037.
263. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40: 168-179.
264. Weber, M. A., Drayer, J. I., McMahon, F. G., Hamburger, R., Shah, A. R. and Kirk, L. N. (1984) Transdermal administration of clondine for treatment of high BP. Arch. Intern. Med. 144: 1211-1213.
265. 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in isolated perfused mesentery of rat. Br. J. Pharmacol. 114: 531-536.
266. 2B-adrenergic receptor subtype. Mol. Pharmacol. 29: 481-486.
267. Wollersheim, H. and Thien, T. (1988) Dose response study of prazosin in Raynaud's phenomenon: clinical effectiveness versus side effects. J. Clin. Pharmacol. 28: 1089-1093.
268. 1-adrenergic receptors is mediated by the α subunits of Gq family. J. Biol. Chem. 267: 25798-25802.
269. Yamamoto, R., Kawasaki, H. and Takasaki, K. (1984) Postsynaptic α-adrenoreceptor populations in several vascular systems of the anaesthetized rat. J. Auton. Pharmacol. 4: 231-239.
270. 2B-adrenoceptor subtypes. Eur. J. Pharmacol. 168: 381-386.
271. 2B-adrenergic receptor. Proc. Natl. Acad. Sci. USA 87: 3102-3106.
272. Zentgraf, M., Baccouche, M. and Junemann, K. P. (1988) Diagnosis and therapy of erectile dynfunction using papaverine and phentolamine. Urol. Int. 43: 65-75.
273. Zorgniotti, A. W. (1994) Experience with buccal phentolamine mesylate for importance. Int. J. Impot. Res. 6: 37-41.